Related Experiment Video
Updated: Dec 5, 2025

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Circ-Tulp4 promotes β-cell adaptation to lipotoxicity by regulating soat1 expression
Liting Wu1, Li Xiong1, Jin Li1,2
1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Abstract:
This study aimed to identify circular RNAs differentially expressed in the islets of type 2 diabetes (T2DM) models and clarify their roles in the control of β-cell functions. Circular RNAs dysregulated in the islets of diabetic db/db mice were identified by high-throughput RNA sequencing. Then, the expression level of the selected circular RNA circ-Tulp4 was confirmed by real-time PCR in the islets of diabetic models and Min6 cells. MTS, EdU, western blot, flow cytometric analysis, and luciferase assay were performed to investigate the impact of circ-Tulp4 on β-cell functions. This study identified thousands of circular RNAs in mouse pancreatic islets. The circ-Tulp4 level significantly decreased in the diabetic models and altered in the Min6 cells under lipotoxic condition. The modulation of circ-Tulp4 level in Min6 cells regulated cell proliferation. Furthermore, an interaction was demonstrated between circ-Tulp4 and miR-7222-3p, which suppressed the expression of cholesterol esterification-related gene, sterol O-acyltransferase 1 (SOAT1). The accumulation of soat1 activated cyclin D1 expression, thus promoting cell cycle progression. These findings showed that circ-Tulp4 regulated β-cell proliferation via miR-7222-3p/soat1/cyclin D1 signaling. Our research suggested that circ-Tulp4 might be a potential therapeutic intervention for T2DM. Besides, soat1 might be important for β-cell adaptation to lipotoxicity.
Insights
Circular RNA circ-Tulp4 is downregulated in type 2 diabetes (T2DM) and regulates beta-cell proliferation. It impacts the miR-7222-3p/SOAT1/cyclin D1 pathway, suggesting circ-Tulp4 as a potential T2DM therapeutic target.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Type 2 diabetes (T2DM) is characterized by beta-cell dysfunction.
- Circular RNAs (circRNAs) are implicated in various diseases, but their role in T2DM beta-cells is not fully understood.
Purpose of the Study:
- To identify differentially expressed circRNAs in T2DM models.
- To investigate the function of circ-Tulp4 in regulating beta-cell function and its underlying molecular mechanisms.
Main Methods:
- High-throughput RNA sequencing to identify dysregulated circRNAs in diabetic mouse islets.
- Real-time PCR to validate circ-Tulp4 expression.
- Cell proliferation assays (MTS, EdU), Western blot, and flow cytometry to assess beta-cell function.
- Luciferase assay to confirm molecular interactions.
Main Results:
- Thousands of circRNAs were identified in mouse pancreatic islets; circ-Tulp4 expression was significantly decreased in diabetic models and under lipotoxic conditions in Min6 cells.
- Modulation of circ-Tulp4 affected Min6 cell proliferation.
- Circ-Tulp4 interacts with miR-7222-3p to suppress SOAT1 expression, leading to SOAT1 accumulation and subsequent activation of cyclin D1, promoting cell cycle progression.
Conclusions:
- Circ-Tulp4 regulates beta-cell proliferation through the miR-7222-3p/SOAT1/cyclin D1 signaling pathway.
- Circ-Tulp4 represents a potential therapeutic target for T2DM.
- SOAT1 may play a crucial role in beta-cell adaptation to lipotoxicity.
More Related Videos
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023